Article Versions Notes

Figueiredo-Junior AT, Marques BCB, Santos DGd, Gouveia WL, Meza RMP, Tinoco LW, Lima LM, Valenca SS, Lanzetti M. Mechanistic Advances in the Therapeutic Application of Bixin for Lung Inflammation In Vitro and In Vivo. Pharmaceuticals. 2025; 18(4):530. https://doi.org/10.3390/ph18040530

Figueiredo-Junior, Alexsandro Tavares, Bruno Clemente Brandão Marques, Douglas Galdino dos Santos, Wesley Leandro Gouveia, Raysa Magali Pillpe Meza, Luzineide Wanderley Tinoco, Lídia Moreira Lima, Samuel Santos Valenca, and Manuella Lanzetti. 2025. "Mechanistic Advances in the Therapeutic Application of Bixin for Lung Inflammation In Vitro and In Vivo" Pharmaceuticals 18, no. 4: 530. https://doi.org/10.3390/ph18040530

Figueiredo-Junior, A. T., Marques, B. C. B., Santos, D. G. d., Gouveia, W. L., Meza, R. M. P., Tinoco, L. W., Lima, L. M., Valenca, S. S., & Lanzetti, M. (2025). Mechanistic Advances in the Therapeutic Application of Bixin for Lung Inflammation In Vitro and In Vivo. Pharmaceuticals, 18(4), 530. https://doi.org/10.3390/ph18040530